The efficacy and safety of novel anti-obesity therapies
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2015, Vol 32, Issue 3
Abstract
Obesity is a chronic disease with a high prevalence in both developed and developing countries. Lifestyle interventions, such as restricting calorie consumption and increasing physical activity, continue to be the cornerstone of weight-reduction programs. Novel anti-obesity drug therapies are currently gaining in importance. These include lorcaserin (a selective serotonin agonist), phentermine/topiramate combination, naltrexone/bupropion combination (acting on the hypothalamus), and liraglutide, an established anti-diabetic agent which suppresses the appetite. This is a brief review of the evidence on the role of these anti-obesity drugs in the management of obesity.
Authors and Affiliations
A. PAPAZAFIROPOULOU, N. PAPANAS
B-chronic lymphocytic leukemia - latest developments
B-chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western countries. Research during the last two decades has contributed to better understanding of the biology of the disease. Two subtypes of C...
The factors contributing to "epidemiological transition" and its consequences in the organization of health care services and the development of health policy
This paper addresses the mechanisms involved in, and the indices that demonstrate, changing patterns of diseases, and explores the reforms in the health care systems which are necessary to cope with the changes. The epid...
Απόστημα του προσπονδυλικού διαστήματος μετά από ένεση κορτικοστεροειδών<br />
The practice of medicine in relation to the limitation of availability of financial resources
It is generally accepted that both the physician and the health system should aim to defend the health of each patient individually and protect the health of the population in general. Nowadays, however, the cost of supp...
ΒΙΒΛΙΟΠΑΡΟΥΣΙΑΣΗ
Βασικές, Ανώτερες και Εξειδικευμένες Νοσηλευτικές Δεξιότητες. Επιμέλεια: G.J. Baltopoulos